A study on correlation between clinical prognostic markers glycated hemoglobin, erythrocyte sedimentation rate and C-reactive protein levels and the stage of disease in malignant otitis externa
DOI:
https://doi.org/10.18203/issn.2454-5929.ijohns20212899Keywords:
Malignant otitis externa, Positron emission tomography-computerized tomography, Single photon emission computed tomography, Skull base osteomyelitis.Abstract
Background: Objectives of the study were to establish a clinical correlation between the stages of MOE and biochemical markers namely glycated Hb (HbA1c), C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) levels, to identify improvement in clinical symptomology in MOE following treatment and to correlate with the duration of diabetes mellitus with treatment outcome.
Methods: Patients with diabetes mellitus, otalgia and ear discharge presenting to ENT OPD were subjected to detailed history and clinical examination. Otoscopic examination was done. Pus from the EAC was taken for culture and sensitivity. Baseline glycated Hb, ESR and CRP levels and HRCT temporal bone in axial and coronal planes was done. According to clinical findings and CT findings the patients were staged using chandlers staging. Patients were followed up after 1st and 2nd month and otoscopic examination with blood tests was repeated and staged accordingly
Results: Fall in the levels of glycated HbA1c serves as a good prognostic indicator of the disease. Duration of diabetes has no significant impact on the disease prognosis. Most common etiologic agent is Pseudomonas aeruginosa. In spite of improvement in clinical features and inflammatory parameters there was no improvement in clinical staging with treatment. There was a significant fall in ESR and CRP values after treatment for 2 months with antibiotics and analgesics.
Conclusions: The study highlights the need to control infection with medical line of treatment which can be monitored by ESR, CRP and glycated HbA1c and that the role for surgical management is limited for stage 1, 2 and 3.
Metrics
References
Slattery WH, Brackmann DE. Skull base osteomyelitis. Malignant external otitis. Otolaryngol Clin North Am. 1996;29(1):806-9.
Lucente FE, Parisier SC, Som PM, Arnold LM. Otolaryngology-Head and Neck Surgery. Malignant external otitis: a dangerous misnomer. 1992;90:266-9.
Sreepada GS, Kwartler JA. Skull base osteomyelitis secondary to malignant otitis externa. Curr Opin Otolaryngol Head Neck Surg. 2003;11:316-23.
Rubin Grandis J, Branstetter BF, Yu VL. The changing face of malignant (necrotising) external otitis: clinical, radiological, and anatomic correlations. Lancet Infect Dis. 2004;4(12):39-5.
Rubin J, Yu VL. Malignant external otitis: insights into pathogenesis, clinical manifestations, diagnosis, and therapy. Am J Med. 1998(6):398-7.
Chandler JR. Malignant external otitis. Laryngoscope. 1968:78(22):1294-37.
Barrow HN, Levenson MJ. Necrotizing ‘malignant’ external otitis caused by Staphylococcus epidermidis. Arch Otolaryngol Head Neck Surg. 1992:118:96-2.
Farr RC, Gardner G, Acker JD. Blastomycotic cranial osteomyelitis. Am J Otol. 1992;13:586-4.
Hern JD, Almeyda J, Thomas DM. Malignant otitis externa in HIV and AIDS. J Laryngol Otol. 1996:110;775-5.
Lancaster J, Alderson DJ, McCormick M. Non-pseudomonal malignant otitis externa and jugular foramen syndrome secondary to cyclosporin-induced hypertrichosis in a diabetic renal transplant patient. J Laryngol Otol. 2000;114:369-3.
Yao M, Messner AH. Fungal malignant otitis externa due to Scedo-sporiumapiospermum. Ann Otol Rhinol Laryngol. 2001;110:380-3.
Cunningham M, Yu VL, Turner J. Necrotizing otitis externa due to Aspergillus in an immunocompetent patient. Arch Otolaryngol Head Neck Surg. 1998;114:556- 2.
Keya DG, Murray JA. Malignant otitis externa due to Staphylococcus infection. J Laryngol Otol. 1998;102:927-1.
Soldati D, Mudry A, Monnier P. Necrotizing otitis externa caused by Staphylococcus epidermidis. Eur Arch Otorhinolaryngol. 1999:256:441-3.
Levenson MJ, Parisier SC, Dolitsky J, Bindra G. Ciprofloxacin: drug of choice in the treatment of malignant external otitis (MEO). Laryngoscope. 1991;101:821-4.
Corey JP, Levandowski RA, Panwalker AP. Prognostic implications of therapy for necrotizing external otitis. Am J Otol. 1995;6:353-8.
Benecke Jr. JE. Management of osteomyelitis of the skullbase. Laryngoscope. 1999;99:1220-3.
Tony Wright and Peter valentine. The anatomy and embryology of the external and middle ear. Chapter 225, In: Gleeson M (eds) Scott-Brown' Otorhinolaryngology, Head and Neck Surgery. 7th Ed. Edward Arnold. 2008;3:3105-20.
Gulya AJ. In: Gulya and Schuknecht’s Anatomy of the Temporal bone with surgical implications 3rd Edn. Informa healthcare. USA: 2007;28-47.
Paul Flint, Bruce Haughey, Valerie Lund, John Niparko K, Robbins J, Regan Thomas Marci Lesperance. Cummings otolaryngology head and neck surgery. 6th ed. United states: Saunders; 2014.
Patel SK, McPartlin DW, Philpott JM, Abramovich S. A case of malignant otitis externa following mastoidectomy. J Laryngol Otol. 1999;1131095-7.
Van Kroonenburgh AMJL, Van der Meer WL, Bothof RJP, Van Tilburg M, Van Tongeren J, Postma AA. Advanced Imaging Techniques in Skull Base Osteomyelitis Due to Malignant Otitis Externa. Curr Radiol Rep. 2018;6(1):3.
Babiatzki A, Sade J. Malignant external otitis. J Laryngol Otol. 1987;101:205-10.
Corberand J, Nguyen F, Fraysse B, Enjalbert L. Malignant external otitis and polymorphonuclear leukocyte migration impairment. Improvement with ascorbic acid. Arch Otolaryngol. 1982;108:122-4.
Driscoll PV, Ramachandrula A, Drezner DA, Hicks TA, Schaffer SR. Characteristics of cerumen in diabetic patients: a key to understanding malignant external otitis? Otolaryngol Head Neck Surg. 1993;109:676-9.
Babiatzki A, Sade J. Malignant external otitis. J Laryngol Otol. 1987;101:205-10.
Corberand J, Nguyen F, Fraysse B, Enjalbert L. Malignant external otitis and polymorphonuclear leukocyte migration impairment. Improvement with ascorbic acid. Arch Otolaryngol. 1982;108:122-4.
Driscoll PV, Ramachandrula A, Drezner DA, Hicks TA, Schaffer SR. Characteristics of cerumen in diabetic patients: a key to understanding malignant external otitis? Otolaryngol Head Neck Surg. 1993;109:676-9.
Shpitzer T, Stern Y, Cohen O, Levy R, Segal K, Feinmesser R. Malignant external otitis in nondiabetic patients. Ann Otol Rhinol Laryngol. 1993;102:870-2.
Rubin J, Yu VL. Malignant external otitis: insights into pathogenesis, clinical manifestations, diagnosis, and therapy. Am J Med. 1998;85:391-8.
McCaffrey TV, McDonald TJ. Histiocytosis X of the ear and temporal bone: review of 22 cases. Laryngoscope. 1999;89:1735-42.
Varma JR, Parler DW. Squamous cell carcinoma of the ear masquerading as malignant otitis externa. J Am Board Family Practice. 1991;4:263-7.
Anonymous. Diagnosis and treatment of acute otitis externa. An interdisciplinary update. Ann Otol Rhinol Laryngol Supplement. 1999;176:1-23.
Reiss P, Hadderingh R, Schot LJ, Danner SA. Invasive external otitis caused by Aspergillus fumigatus in two patients with AIDS. AIDS. 1991;5:605-6.
Downloads
Published
How to Cite
Issue
Section
